Return to homepagePandemic Pact

to develop low cost of goods sold (COGS) COVID vaccine for low- and middle-income countries (LMICs)

Grant number: INV-038053

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Known Financial Commitments (USD)

    $1,577,476

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    Inventprise, Inc.

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A

1 Publication linked via Europe PMC

Last Updated:3 days ago

View all publications at Europe PMC

SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants.